Alacra Pulse Banner
 

Antares Pharma Incorporated (AIS)

Search Street Pulse:
 
 
Follow Alacra Pulse on Twitter
Latest Analyst Comments on Antares Pharma Incorporated (AIS)
 

Merriman Curhan Ford Initiates Coverage on Antares Pharma (AIS) with a Buy; Cutting Edge Drug Delivery Business (StreetInsider.com - New Coverage) - Nov 17, 2009

Merriman analyst says, "We believe Antares represents a strong value play in the drug delivery space.  
 
Share:  <span class="analyst">Merriman</span> analyst says, "We believe <span class="company">Antares</span> represents a strong value play in the drug delivery space. Tweet this 

Teva, Antares get FDA nod for needle-free device (Reuters India) - Jun 29, 2009

"This is an important validation of the Teva partnership, which is the primary driver of our valuation and excitement about Antares stock," Ladenburg Thalmann analyst Matthew Kaplan said by phone. Shares of Antares rose as much as 58 percent to a new year high of $1.14, before paring some gains to trade up at $1.02 in morning trade Monday on the American Stock Exchange. 
Matthew Kaplan
Matthew Kaplan
Quotability Index: the stars indicate how frequently this analyst is quoted in the Street Pulse sources. Five stars represent the top quintile, four stars the next and so forth.  
Share:  "This is an important validation of the Teva partnership, which is the primary driver of our valuation and excitement about <span class="company">Antares</span> stock," Ladenburg Thalmann analyst <span class="analyst">Matthew Kaplan</span> said by phone. Tweet this 

Analyst Comment Ticker
 
Key:
  • Sell-side Sell-side
  • Blog Blog
  • Credit Analyst Credit
  • Industry Analyst Industry

Copyright © 2010 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.

Reproduction in whole or in part in any form or medium without express written permission is prohibited.